The effects of Nrf2 activators and oxidative stress on COPD alveolar macrophages
J. Li (Manchester (Greater Manchester), United Kingdom), J. Baker (Manchester (Greater Manchester), United Kingdom), C. Murray (Manchester (Greater Manchester), United Kingdom), N. Cooper (Manchester (Greater Manchester), United Kingdom), C. Lucas (Manchester (Greater Manchester), United Kingdom), C. Fox (Manchester (Greater Manchester), United Kingdom), D. Singh (Manchester (Greater Manchester), United Kingdom), S. Lea (Manchester (Greater Manchester), United Kingdom)
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Session: Scientific advances in airway pharmacology
Session type: E-poster session
Number: 3307
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Li (Manchester (Greater Manchester), United Kingdom), J. Baker (Manchester (Greater Manchester), United Kingdom), C. Murray (Manchester (Greater Manchester), United Kingdom), N. Cooper (Manchester (Greater Manchester), United Kingdom), C. Lucas (Manchester (Greater Manchester), United Kingdom), C. Fox (Manchester (Greater Manchester), United Kingdom), D. Singh (Manchester (Greater Manchester), United Kingdom), S. Lea (Manchester (Greater Manchester), United Kingdom). The effects of Nrf2 activators and oxidative stress on COPD alveolar macrophages. 3307
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: